$ELMD

Electromed, Inc.

Insider trades

No enriched coverage for $ELMD in the last 7 days.

No SEC Form 4 filings for $ELMD in the last 30 days.

See all $ELMD insider activity →
Low

Cunniff James L. sold $354K of ELMD

Cunniff James L. (CEO and President) sold 9,700 shares of Electromed, Inc. (ELMD) at an average of $36.50 ($36.25–$37.77, $0.35M total) across 3 trades on 2026-06-08.

Nagel Bradley M. sold $429K of ELMD

Nagel Bradley M. (Chief Financial Officer) sold 11,801 shares of Electromed, Inc. (ELMD) at an average of $36.35 ($36.34–$37.11, $0.43M total) across 2 trades on 2026-06-04.

ELMD sentiment & insider activity

Recent ELMD coverage spans financial news and insider activity.

What's driving ELMD

  • This is a routine insider sale with no stated 10b5-1 plan, but it does not disclose new company fundamentals.

    SEC EDGAR · Jun 9, 2026

  • This is a routine insider sale with no stated operational or financial catalyst, so near-term price impact is likely limited.

    SEC EDGAR · Jun 8, 2026

  • Recent insider selling of Electromed (ELMD) shares worth approximately $1.42 million indicates potential insider caution, aligning with bearish sentiment.

    Moomoo · May 20, 2026

  • The filing suggests an upcoming share sale by Electromed, Inc., which could exert mild downward pressure on the stock price due to increased supply.

    Stock Titan · May 16, 2026

  • Electromed (ELMD) is positioned as a solid growth stock with potential for exceptional returns based on recent growth attributes.

    Zacks Commentary · Nov 14, 2025

alphai scores every news story that mentions ELMD with an AI model for sentiment and relevance, and aggregates insider trades from Electromed, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ELMD

Score
$ELMDLow

[144] Electromed, Inc. SEC Filing

This article details an SEC Form 144 filing by Electromed, Inc. (ELMD) concerning a proposed sale of 40,000 shares of common stock with an aggregate market value of $1,419,357.79. The securities were acquired via an option grant on July 1, 2016, and are intended for sale on May 15, 2026, through Fidelity Brokerage Services. The filing indicates a neutral impact and sentiment.

Related tickers